Company Search:
Advanced Search
Sponsored Links
Enzymatica AB (publ) Company Snapshot
Enzymatica AB (publ) operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Enzymatica AB (publ) with three other pharmaceutical manufacturers in Europe: Mithra Pharmaceuticals SA of BELGIUM (2020 sales of 9.03 million Euros [US$10.85 million] of which 60% was Out-licensing), Arcticzymes Technologies ASA of NORWAY (93.45 million Norwegian Kroner [US$11.21 million] ), and Dbv Technologies which is based in FRANCE (9.83 million Euros [US$11.81 million] of which 100% was immunotherapy products).

Sales Analysis. During the year ended December of 2020, sales at Enzymatica AB (publ) were SEK 111.25 million (US$13.11 million). This is an increase of 81.5% versus 2019, when the company's sales were SEK 61.31 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Enzymatica AB (publ)
  Stock Performance Chart for Enzymatica AB (publ)
  Stock Data: Recent Stock Performance:
  Current Price (4/30/2021): 10.36
(Figures in Swedish Kronor)
1 Week 8.8%   13 Weeks -2.8%  
4 Weeks -45.6%   52 Weeks 10.7%  
Enzymatica AB (publ) Key Data:
  Ticker: ENZY Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 111,245,000
(Year Ending Jan 2021).
Employees: 20
  Currency: Swedish Kronor Market Cap: 1,479,653,491
  Fiscal Yr Ends: December Shares Outstanding: 142,823,696
  Share Type: Aktie Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.